Pre-Open Stock Movers 06/11: (NOVN) (PGEN) (AMEH) Higher; (VRTX) (ELY) (SNOW) Lower (more...)
Get Alerts PGEN Hot Sheet
Join SI Premium – FREE
Pre-Open Stock Movers:
Novan, Inc. (Nasdaq: NOVN) 59% HIGHER; announced positive topline efficacy and safety results for the B-SIMPLE4 pivotal Phase 3 clinical study of SB206, a topical antiviral gel, for the treatment of molluscum contagiosum (molluscum). Molluscum is a common, contagious skin infection caused by the molluscipoxvirus, affecting approximately six million people in the U.S. annually, with the greatest incidence in children aged one to 14 years. The Company will host a video webcast, today, June 11, 2021, at 8:00 a.m. ET (details below) to discuss the results of the study.
Vertex Pharma (NASDAQ: VRTX) 13.2% LOWER; halts further trials of VX-864 - its drug candidate for treatment of inherited lung disease - noting the Phase 2 study of VX-864 has demonstrated "magnitude of treatment effect observed in this study is unlikely to translate into substantial clinical benefit".
Apollo Medical Holdings Inc. (NASDAQ: AMEH) 11% HIGHER; will replace Callaway Golf in the S&P SmallCap 600
Atotech Ltd. (NYSE: ATC) 7.1% HIGHER; MKS Instruments (NASDAQ: MKSI) has approached Atotech Ltd. (NYSE: ATC) with an acquisition offer, according to Reuters, citing people familiar with the matter.
PlayAGS, Inc. (NYSE: AGS) 5.6% HIGHER; B.Riley David Bain initiates coverage with a Buy rating and a price target of $21.00.
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) 5.2% HIGHER; gains on VRTX setback.
Callaway Golf Co. (NYSE: ELY) 4.5% LOWER; will replace GrubHub Inc. (NYSE: GRUB) in the S&P MidCap 400
Dave & Buster's Entertainment (NASDAQ: PLAY) 3.8% HIGHER; reported Q1 EPS of ($0.40), which may not compare to the analyst estimate of ($0.16). Revenue for the quarter came in at $265.3 million versus the consensus estimate of $257.98 million. Dave & Buster's Entertainment sees Q2 2021 revenue of $335-350 million, versus the consensus of $287.4 million.
Tyme Technologies (NASDAQ: TYME) 3.8% HIGHER; earnings and completion of strategic review. The company announced a new OASIS Breast Cancer Trial for its drug candidate SM-88 in conjunction with Georgetown University.
Snowflake (NYSE: SNOW) 3.7% LOWER; Investor Day Ongoing
Agree Realty Corporation (NYSE: ADC) 3.5% LOWER; today announced that it commenced an underwritten public offering of 4,000,000 shares of its common stock.
Chewy (NYSE: CHWY) 1% LOWER; reported Q1 EPS of $0.09, $0.12 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $2.14 billion versus the consensus estimate of $2.13 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trian Sends Letter to Fellow Disney Shareholders Outlining the Need for Change
- Bakkt Holdings, Inc. (BKKT) Announces Leadership Transition
- DraftKings (DKNG) Announces Leadership Changes to Increase Focus on Operational Efficiencies
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Standard & Poor's, Earnings, Pre-Open Losers, Pre-Open Winners, Definitive Agreement, Pre Market MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!